Structuring private equity (PE) funds has generally followed a tried-and-tested process – a closed-end fund with a defined fund life
Asia Impact Investor ABC World Asia Leads US$24M Series B Round in Kim Dental
Kim Dental delivers comprehensive oral care services of international dental standards to over 370,000 patients across Vietnam
Aura Private Equity’s fund Aura Vietnam Dental Fund 2 today announced its follow-on investment into Kim Health Care Group Corporation’s (“Kim Health Care’s”) Series B financing round.
This US$24m Series B round is led by ABC World Asia, the Singapore-based and Temasek-affiliated private equity fund dedicated to impact investing across Asia. Aura Vietnam Dental Fund 2 is Aura Private Equity’s largest SPV Private Equity fund to date.
Kim Health Care owns Kim Dental (“Kim”) and Labo A&B (“Labo) and has treated more than one million patients to date. Established in 2010, Kim was founded with the vision to transform Vietnam’s healthcare industry, by providing high-quality healthcare at affordable prices to the rapidly growing Vietnamese middle-class population. Kim is now by far the leading dental clinic chain in Vietnam with 19 well-equipped operating clinics that have the state-of-the-art medical equipment to be fully compliant with the highest medical and regulatory standards. The clinics provide routine dental hygiene check-ups and treatments as well as more advanced procedures such as orthodontics, prosthodontics, oral surgery and implants.
At the same time, Kim is being supported by its in-house dental laboratory, Labo, which supplies Kim with high-quality in-house production of dental crowns, dentures and bridge products. Labo has been EBITDA-positive since its first year of operation and its strong in-house QA/QC team has also achieved ISO 9001 2015 and ISO 13485O certifications.
Andrew Nai, Director of Aura Private Equity commented, “Aura Private Equity was an early investor in Kim Dental and is proud to follow on in this landmark Series B round led by ABC World Asia. Aura Private Equity was attracted to Kim Dental as it is the market leader in Vietnam providing world-class oral hygiene services at very affordable prices. We see strong community outcomes as well as a significant market opportunity in Vietnam for reasonably priced healthcare services. This transaction is a significant milestone for Aura Private Equity in Asia, especially in light of the market conditions created by COVID-19. It is also our first collaboration with ABC World Asia. We are delighted to partner with ABC World Asia to continue to support Kim Dental’s entrepreneurial founders in further scaling their business across Vietnam.”
The World Health Organisation estimates that oral diseases affect around 3.5 billion people globally1. In low-middle income and emerging markets, the incidence rate of oral diseases is expected to rise as more people are exposed to sugar, tobacco and alcohol – the main risk factors for oral diseases. The National Oral Health Survey2 conducted in Vietnam found that one-third of Vietnamese adults suffer from periodontal pockets as a result of gum disease that was left untreated.
The strong management team that founded Kim and Labo is passionate to grow their business to realise its full potential in serving Vietnam’s rapidly growing middle-class population. With access to an increasing disposable income and private healthcare spending.
This information is for wholesale or sophisticated investors only and is provided by Aura Group and related entities and is only for information and general news purposes. It does not constitute an offer or invitation of any sort in any jurisdiction. Moreover, the information in this document will not affect Aura Group’s investment strategy for any funds in any way. The information and opinions in this document have been derived from or reached from sources believed in good faith to be reliable but have not been independently verified. Aura Group makes no guarantee, representation or warranty, express or implied, and accepts no responsibility or liability for the accuracy or completeness of this information. No reliance should be placed on any assumptions, forecasts, projections, estimates or prospects contained within this document. You should not construe any such information or any material, as legal, tax, investment, financial, or other advice. This information is intended for distribution only in those jurisdictions and to those persons where and to whom it may be lawfully distributed. All information is of a general nature and does not address the personal circumstances of any particular individual or entity. The views and opinions expressed in this material are those of the author as of the date indicated and any such views are subject to change at any time based upon market or other conditions. The information may contain certain statements deemed to be forward-looking statements, including statements that address results or developments that Aura expects or anticipates may occur in the future. Any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected in the forward-looking statements. This information is for the use of only those persons to whom it is given. If you are not the intended recipient, you must not disclose, redistribute or use the information in any way.
Aura Group subsidiaries issuing this information include Aura Group (Singapore) Pte Ltd (Registration No. 201537140R) a Registered Fund Management Company (RFMC) in Singapore and Aura Capital Pty Ltd (ACN 143 700 887) Australian Financial Services Licence 366230 holder in Australia and is issued to accredited, qualified, wholesale, sophisticated and institutional investors only.